APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lisdexamfetamine Dimesylate Generics

Compare research editions
View pricing & licenses

Selected research

Industry Research

Lisdexamfetamine Dimesylate Generics Industry Research Report 2026

27 December 2025121 pages

Choose your research edition.

Industry ResearchLisdexamfetamine Dimesylate Generics Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Lisdexamfetamine Dimesylate Generics Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Lisdexamfetamine Dimesylate Generics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lisdexamfetamine Dimesylate Generics Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Lisdexamfetamine Dimesylate Generics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Lisdexamfetamine Dimesylate Generics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Lisdexamfetamine Dimesylate Generics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Lisdexamfetamine Dimesylate Generics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Lisdexamfetamine Dimesylate Generics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Lisdexamfetamine Dimesylate Generics include Zhejiang Huahai Pharmaceutical, Teva Pharmaceutical, Sandoz, Mylan, Sun Pharmaceutical Industries Ltd, Mallinckrodt PLC, Lannett, Hikma Pharmaceuticals and Ascent Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Lisdexamfetamine Dimesylate Generics market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Lisdexamfetamine Dimesylate Generics Market by Company

Zhejiang Huahai Pharmaceutical

Teva Pharmaceutical

Sandoz

Mylan

Sun Pharmaceutical Industries Ltd

Mallinckrodt PLC

Lannett

Hikma Pharmaceuticals

Ascent Pharmaceuticals

Apotex

Amneal Pharmaceuticals

Alkem Laboratories

Lisdexamfetamine Dimesylate Generics Segment by Type

Capsules

Chewable Tablets

Lisdexamfetamine Dimesylate Generics Segment by Application

Attention Deficit Hyperactivity Disorder(ADHD)

Bulimia

Other

Lisdexamfetamine Dimesylate Generics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lisdexamfetamine Dimesylate Generics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lisdexamfetamine Dimesylate Generics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lisdexamfetamine Dimesylate Generics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Lisdexamfetamine Dimesylate Generics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Lisdexamfetamine Dimesylate Generics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Lisdexamfetamine Dimesylate Generics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Lisdexamfetamine Dimesylate Generics Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Lisdexamfetamine Dimesylate Generics Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Manufacturers (2021-2026) Table 8. Global Lisdexamfetamine Dimesylate Generics Revenue of Manufacturers (2021-2026) Table 9. Global Lisdexamfetamine Dimesylate Generics Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Lisdexamfetamine Dimesylate Generics Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Lisdexamfetamine Dimesylate Generics Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Lisdexamfetamine Dimesylate Generics, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Lisdexamfetamine Dimesylate Generics, Product Type & Application Table 14. Global Lisdexamfetamine Dimesylate Generics Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Lisdexamfetamine Dimesylate Generics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zhejiang Huahai Pharmaceutical Company Information Table 19. Zhejiang Huahai Pharmaceutical Business Overview Table 20. Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Generics Product Portfolio Table 22. Zhejiang Huahai Pharmaceutical Recent Developments Table 23. Teva Pharmaceutical Company Information Table 24. Teva Pharmaceutical Business Overview Table 25. Teva Pharmaceutical Lisdexamfetamine Dimesylate Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Teva Pharmaceutical Lisdexamfetamine Dimesylate Generics Product Portfolio Table 27. Teva Pharmaceutical Recent Developments Table 28. Sandoz Company Information Table 29. Sandoz Business Overview Table 30. Sandoz Lisdexamfetamine Dimesylate Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Sandoz Lisdexamfetamine Dimesylate Generics Product Portfolio Table 32. Sandoz Recent Developments Table 33. Mylan Company Information Table 34. Mylan Business Overview Table 35. Mylan Lisdexamfetamine Dimesylate Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Mylan Lisdexamfetamine Dimesylate Generics Product Portfolio Table 37. Mylan Recent Developments Table 38. Sun Pharmaceutical Industries Ltd Company Information Table 39. Sun Pharmaceutical Industries Ltd Business Overview Table 40. Sun Pharmaceutical Industries Ltd Lisdexamfetamine Dimesylate Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Sun Pharmaceutical Industries Ltd Lisdexamfetamine Dimesylate Generics Product Portfolio Table 42. Sun Pharmaceutical Industries Ltd Recent Developments Table 43. Mallinckrodt PLC Company Information Table 44. Mallinckrodt PLC Business Overview Table 45. Mallinckrodt PLC Lisdexamfetamine Dimesylate Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Mallinckrodt PLC Lisdexamfetamine Dimesylate Generics Product Portfolio Table 47. Mallinckrodt PLC Recent Developments Table 48. Lannett Company Information Table 49. Lannett Business Overview Table 50. Lannett Lisdexamfetamine Dimesylate Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Lannett Lisdexamfetamine Dimesylate Generics Product Portfolio Table 52. Lannett Recent Developments Table 53. Hikma Pharmaceuticals Company Information Table 54. Hikma Pharmaceuticals Business Overview Table 55. Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Generics Product Portfolio Table 57. Hikma Pharmaceuticals Recent Developments Table 58. Ascent Pharmaceuticals Company Information Table 59. Ascent Pharmaceuticals Business Overview Table 60. Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Generics Product Portfolio Table 62. Ascent Pharmaceuticals Recent Developments Table 63. Apotex Company Information Table 64. Apotex Business Overview Table 65. Apotex Lisdexamfetamine Dimesylate Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Apotex Lisdexamfetamine Dimesylate Generics Product Portfolio Table 67. Apotex Recent Developments Table 68. Amneal Pharmaceuticals Company Information Table 69. Amneal Pharmaceuticals Business Overview Table 70. Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Generics Product Portfolio Table 72. Amneal Pharmaceuticals Recent Developments Table 73. Alkem Laboratories Company Information Table 74. Alkem Laboratories Business Overview Table 75. Alkem Laboratories Lisdexamfetamine Dimesylate Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Alkem Laboratories Lisdexamfetamine Dimesylate Generics Product Portfolio Table 77. Alkem Laboratories Recent Developments Table 78. Global Lisdexamfetamine Dimesylate Generics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global Lisdexamfetamine Dimesylate Generics Sales by Region (2021-2026) & (K Units) Table 80. Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Region (2021-2026) Table 81. Global Lisdexamfetamine Dimesylate Generics Sales by Region (2027-2032) & (K Units) Table 82. Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Region (2027-2032) Table 83. Global Lisdexamfetamine Dimesylate Generics Revenue by Region (2021-2026) & (US$ Million) Table 84. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Region (2021-2026) Table 85. Global Lisdexamfetamine Dimesylate Generics Revenue by Region (2027-2032) & (US$ Million) Table 86. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Region (2027-2032) Table 87. North America Lisdexamfetamine Dimesylate Generics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2026) & (K Units) Table 89. North America Lisdexamfetamine Dimesylate Generics Sales by Country (2027-2032) & (K Units) Table 90. North America Lisdexamfetamine Dimesylate Generics Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Lisdexamfetamine Dimesylate Generics Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe Lisdexamfetamine Dimesylate Generics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2026) & (K Units) Table 94. Europe Lisdexamfetamine Dimesylate Generics Sales by Country (2027-2032) & (K Units) Table 95. Europe Lisdexamfetamine Dimesylate Generics Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Lisdexamfetamine Dimesylate Generics Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific Lisdexamfetamine Dimesylate Generics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2026) & (K Units) Table 99. Asia Pacific Lisdexamfetamine Dimesylate Generics Sales by Country (2027-2032) & (K Units) Table 100. Asia Pacific Lisdexamfetamine Dimesylate Generics Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific Lisdexamfetamine Dimesylate Generics Revenue by Country (2027-2032) & (US$ Million) Table 102. South America Lisdexamfetamine Dimesylate Generics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2026) & (K Units) Table 104. South America Lisdexamfetamine Dimesylate Generics Sales by Country (2027-2032) & (K Units) Table 105. South America Lisdexamfetamine Dimesylate Generics Revenue by Country (2021-2026) & (US$ Million) Table 106. South America Lisdexamfetamine Dimesylate Generics Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa Lisdexamfetamine Dimesylate Generics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2026) & (K Units) Table 109. Middle East and Africa Lisdexamfetamine Dimesylate Generics Sales by Country (2027-2032) & (K Units) Table 110. Middle East and Africa Lisdexamfetamine Dimesylate Generics Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa Lisdexamfetamine Dimesylate Generics Revenue by Country (2027-2032) & (US$ Million) Table 112. Global Lisdexamfetamine Dimesylate Generics Sales by Type (2021-2026) & (K Units) Table 113. Global Lisdexamfetamine Dimesylate Generics Sales by Type (2027-2032) & (K Units) Table 114. Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Type (2021-2026) Table 115. Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Type (2027-2032) Table 116. Global Lisdexamfetamine Dimesylate Generics Revenue by Type (2021-2026) & (US$ Million) Table 117. Global Lisdexamfetamine Dimesylate Generics Revenue by Type (2027-2032) & (US$ Million) Table 118. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Type (2021-2026) Table 119. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Type (2027-2032) Table 120. Global Lisdexamfetamine Dimesylate Generics Price by Type (2021-2026) & (US$/Unit) Table 121. Global Lisdexamfetamine Dimesylate Generics Price by Type (2027-2032) & (US$/Unit) Table 122. Global Lisdexamfetamine Dimesylate Generics Sales by Application (2021-2026) & (K Units) Table 123. Global Lisdexamfetamine Dimesylate Generics Sales by Application (2027-2032) & (K Units) Table 124. Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Application (2021-2026) Table 125. Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Application (2027-2032) Table 126. Global Lisdexamfetamine Dimesylate Generics Revenue by Application (2021-2026) & (US$ Million) Table 127. Global Lisdexamfetamine Dimesylate Generics Revenue by Application (2027-2032) & (US$ Million) Table 128. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Application (2021-2026) Table 129. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Application (2027-2032) Table 130. Global Lisdexamfetamine Dimesylate Generics Price by Application (2021-2026) & (US$/Unit) Table 131. Global Lisdexamfetamine Dimesylate Generics Price by Application (2027-2032) & (US$/Unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Lisdexamfetamine Dimesylate Generics Distributors List Table 135. Lisdexamfetamine Dimesylate Generics Customers List Table 136. Lisdexamfetamine Dimesylate Generics Industry Trends Table 137. Lisdexamfetamine Dimesylate Generics Industry Drivers Table 138. Lisdexamfetamine Dimesylate Generics Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Lisdexamfetamine Dimesylate Generics Product Image Figure 5. Global Lisdexamfetamine Dimesylate Generics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Lisdexamfetamine Dimesylate Generics Market Size (2021-2032) & (US$ Million) Figure 7. Global Lisdexamfetamine Dimesylate Generics Sales (2021-2032) & (K Units) Figure 8. Global Lisdexamfetamine Dimesylate Generics Average Price (US$/Unit) & (2021-2032) Figure 9. Capsules Product Image Figure 10. Chewable Tablets Product Image Figure 11. Attention Deficit Hyperactivity Disorder(ADHD) Product Image Figure 12. Bulimia Product Image Figure 13. Other Product Image Figure 14. Global Lisdexamfetamine Dimesylate Generics Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Lisdexamfetamine Dimesylate Generics, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Lisdexamfetamine Dimesylate Generics Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Lisdexamfetamine Dimesylate Generics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Lisdexamfetamine Dimesylate Generics Sales by Region in 2025 Figure 20. Global Lisdexamfetamine Dimesylate Generics Revenue by Region in 2025 Figure 21. North America Lisdexamfetamine Dimesylate Generics Market Size by Country in 2025 Figure 22. North America Lisdexamfetamine Dimesylate Generics Sales Market Share by Country (2021-2032) Figure 23. North America Lisdexamfetamine Dimesylate Generics Revenue Market Share by Country (2021-2032) Figure 24. United States Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Lisdexamfetamine Dimesylate Generics Market Size by Country in 2025 Figure 28. Europe Lisdexamfetamine Dimesylate Generics Sales Market Share by Country (2021-2032) Figure 29. Europe Lisdexamfetamine Dimesylate Generics Revenue Market Share by Country (2021-2032) Figure 30. Germany Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Lisdexamfetamine Dimesylate Generics Market Size by Country in 2025 Figure 41. Asia Pacific Lisdexamfetamine Dimesylate Generics Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Lisdexamfetamine Dimesylate Generics Revenue Market Share by Country (2021-2032) Figure 43. China Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Lisdexamfetamine Dimesylate Generics Market Size by Country in 2025 Figure 52. South America Lisdexamfetamine Dimesylate Generics Sales Market Share by Country (2021-2032) Figure 53. South America Lisdexamfetamine Dimesylate Generics Revenue Market Share by Country (2021-2032) Figure 54. Brazil Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Lisdexamfetamine Dimesylate Generics Market Size by Country in 2025 Figure 58. Middle East and Africa Lisdexamfetamine Dimesylate Generics Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Lisdexamfetamine Dimesylate Generics Revenue Market Share by Country (2021-2032) Figure 60. Egypt Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Lisdexamfetamine Dimesylate Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Type (2021-2032) Figure 66. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Type (2021-2032) Figure 67. Global Lisdexamfetamine Dimesylate Generics Price (US$/Unit) by Type (2021-2032) Figure 68. Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Application (2021-2032) Figure 69. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Application (2021-2032) Figure 70. Global Lisdexamfetamine Dimesylate Generics Price (US$/Unit) by Application (2021-2032) Figure 71. Lisdexamfetamine Dimesylate Generics Value Chain Figure 72. Lisdexamfetamine Dimesylate Generics Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Lisdexamfetamine Dimesylate Generics Industry Opportunities and Challenges

Scope & coverage.

Types
  • Capsules
  • Chewable Tablets
Applications
  • Attention Deficit Hyperactivity Disorder(ADHD)
  • Bulimia
  • Other
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • Teva Pharmaceutical
  • Sandoz
  • Mylan
  • Sun Pharmaceutical Industries Ltd
  • Mallinckrodt PLC
  • Lannett
  • Hikma Pharmaceuticals
  • Ascent Pharmaceuticals
  • Apotex
  • Amneal Pharmaceuticals
  • Alkem Laboratories

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Lisdexamfetamine Dimesylate Generics Market Size (2021-2032)
  4. 2.2.2 Global Lisdexamfetamine Dimesylate Generics Sales (2021-2032)
  5. 2.2.3 Global Lisdexamfetamine Dimesylate Generics Market Average Price (2021-2032)
  6. 2.3 Lisdexamfetamine Dimesylate Generics by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Capsules
  9. 2.3.3 Chewable Tablets
  10. 2.4 Lisdexamfetamine Dimesylate Generics by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Attention Deficit Hyperactivity Disorder(ADHD)
  13. 2.4.3 Bulimia
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Lisdexamfetamine Dimesylate Generics Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Lisdexamfetamine Dimesylate Generics Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Lisdexamfetamine Dimesylate Generics Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Lisdexamfetamine Dimesylate Generics Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Lisdexamfetamine Dimesylate Generics Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Lisdexamfetamine Dimesylate Generics, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Lisdexamfetamine Dimesylate Generics, Product Type & Application
  8. 3.8 Global Manufacturers of Lisdexamfetamine Dimesylate Generics, Established Date
  9. 3.9 Global Lisdexamfetamine Dimesylate Generics Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zhejiang Huahai Pharmaceutical
  2. 4.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 4.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 4.1.3 Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Generics Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Generics Product Portfolio
  6. 4.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 4.2 Teva Pharmaceutical
  8. 4.2.1 Teva Pharmaceutical Company Information
  9. 4.2.2 Teva Pharmaceutical Business Overview
  10. 4.2.3 Teva Pharmaceutical Lisdexamfetamine Dimesylate Generics Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Teva Pharmaceutical Lisdexamfetamine Dimesylate Generics Product Portfolio
  12. 4.2.5 Teva Pharmaceutical Recent Developments
  13. 4.3 Sandoz
  14. 4.3.1 Sandoz Company Information
  15. 4.3.2 Sandoz Business Overview
  16. 4.3.3 Sandoz Lisdexamfetamine Dimesylate Generics Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Sandoz Lisdexamfetamine Dimesylate Generics Product Portfolio
  18. 4.3.5 Sandoz Recent Developments
  19. 4.4 Mylan
  20. 4.4.1 Mylan Company Information
  21. 4.4.2 Mylan Business Overview
  22. 4.4.3 Mylan Lisdexamfetamine Dimesylate Generics Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Mylan Lisdexamfetamine Dimesylate Generics Product Portfolio
  24. 4.4.5 Mylan Recent Developments
  25. 4.5 Sun Pharmaceutical Industries Ltd
  26. 4.5.1 Sun Pharmaceutical Industries Ltd Company Information
  27. 4.5.2 Sun Pharmaceutical Industries Ltd Business Overview
  28. 4.5.3 Sun Pharmaceutical Industries Ltd Lisdexamfetamine Dimesylate Generics Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Sun Pharmaceutical Industries Ltd Lisdexamfetamine Dimesylate Generics Product Portfolio
  30. 4.5.5 Sun Pharmaceutical Industries Ltd Recent Developments
  31. 4.6 Mallinckrodt PLC
  32. 4.6.1 Mallinckrodt PLC Company Information
  33. 4.6.2 Mallinckrodt PLC Business Overview
  34. 4.6.3 Mallinckrodt PLC Lisdexamfetamine Dimesylate Generics Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Mallinckrodt PLC Lisdexamfetamine Dimesylate Generics Product Portfolio
  36. 4.6.5 Mallinckrodt PLC Recent Developments
  37. 4.7 Lannett
  38. 4.7.1 Lannett Company Information
  39. 4.7.2 Lannett Business Overview
  40. 4.7.3 Lannett Lisdexamfetamine Dimesylate Generics Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Lannett Lisdexamfetamine Dimesylate Generics Product Portfolio
  42. 4.7.5 Lannett Recent Developments
  43. 4.8 Hikma Pharmaceuticals
  44. 4.8.1 Hikma Pharmaceuticals Company Information
  45. 4.8.2 Hikma Pharmaceuticals Business Overview
  46. 4.8.3 Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Generics Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Generics Product Portfolio
  48. 4.8.5 Hikma Pharmaceuticals Recent Developments
  49. 4.9 Ascent Pharmaceuticals
  50. 4.9.1 Ascent Pharmaceuticals Company Information
  51. 4.9.2 Ascent Pharmaceuticals Business Overview
  52. 4.9.3 Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Generics Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Generics Product Portfolio
  54. 4.9.5 Ascent Pharmaceuticals Recent Developments
  55. 4.10 Apotex
  56. 4.10.1 Apotex Company Information
  57. 4.10.2 Apotex Business Overview
  58. 4.10.3 Apotex Lisdexamfetamine Dimesylate Generics Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Apotex Lisdexamfetamine Dimesylate Generics Product Portfolio
  60. 4.10.5 Apotex Recent Developments
  61. 4.11 Amneal Pharmaceuticals
  62. 4.11.1 Amneal Pharmaceuticals Company Information
  63. 4.11.2 Amneal Pharmaceuticals Business Overview
  64. 4.11.3 Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Generics Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Generics Product Portfolio
  66. 4.11.5 Amneal Pharmaceuticals Recent Developments
  67. 4.12 Alkem Laboratories
  68. 4.12.1 Alkem Laboratories Company Information
  69. 4.12.2 Alkem Laboratories Business Overview
  70. 4.12.3 Alkem Laboratories Lisdexamfetamine Dimesylate Generics Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Alkem Laboratories Lisdexamfetamine Dimesylate Generics Product Portfolio
  72. 4.12.5 Alkem Laboratories Recent Developments
5 Global Lisdexamfetamine Dimesylate Generics Market Scenario by Region
  1. 5.1 Global Lisdexamfetamine Dimesylate Generics Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Lisdexamfetamine Dimesylate Generics Sales by Region: 2021-2032
  3. 5.2.1 Global Lisdexamfetamine Dimesylate Generics Sales by Region: 2021-2026
  4. 5.2.2 Global Lisdexamfetamine Dimesylate Generics Sales by Region: 2027-2032
  5. 5.3 Global Lisdexamfetamine Dimesylate Generics Revenue by Region: 2021-2032
  6. 5.3.1 Global Lisdexamfetamine Dimesylate Generics Revenue by Region: 2021-2026
  7. 5.3.2 Global Lisdexamfetamine Dimesylate Generics Revenue by Region: 2027-2032
  8. 5.4 North America Lisdexamfetamine Dimesylate Generics Market Facts & Figures by Country
  9. 5.4.1 North America Lisdexamfetamine Dimesylate Generics Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2032)
  11. 5.4.3 North America Lisdexamfetamine Dimesylate Generics Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Lisdexamfetamine Dimesylate Generics Market Facts & Figures by Country
  16. 5.5.1 Europe Lisdexamfetamine Dimesylate Generics Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2032)
  18. 5.5.3 Europe Lisdexamfetamine Dimesylate Generics Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Lisdexamfetamine Dimesylate Generics Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Lisdexamfetamine Dimesylate Generics Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Lisdexamfetamine Dimesylate Generics Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Lisdexamfetamine Dimesylate Generics Market Facts & Figures by Country
  41. 5.7.1 South America Lisdexamfetamine Dimesylate Generics Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2032)
  43. 5.7.3 South America Lisdexamfetamine Dimesylate Generics Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Lisdexamfetamine Dimesylate Generics Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Lisdexamfetamine Dimesylate Generics Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Lisdexamfetamine Dimesylate Generics Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Lisdexamfetamine Dimesylate Generics Sales by Type (2021-2032)
  2. 6.1.1 Global Lisdexamfetamine Dimesylate Generics Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Type (2021-2032)
  4. 6.2 Global Lisdexamfetamine Dimesylate Generics Revenue by Type (2021-2032)
  5. 6.2.1 Global Lisdexamfetamine Dimesylate Generics Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Lisdexamfetamine Dimesylate Generics Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Lisdexamfetamine Dimesylate Generics Sales by Application (2021-2032)
  2. 7.1.1 Global Lisdexamfetamine Dimesylate Generics Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Application (2021-2032)
  4. 7.2 Global Lisdexamfetamine Dimesylate Generics Revenue by Application (2021-2032)
  5. 7.2.1 Global Lisdexamfetamine Dimesylate Generics Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Lisdexamfetamine Dimesylate Generics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Lisdexamfetamine Dimesylate Generics Value Chain Analysis
  2. 8.1.1 Lisdexamfetamine Dimesylate Generics Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Lisdexamfetamine Dimesylate Generics Production Mode & Process
  5. 8.2 Lisdexamfetamine Dimesylate Generics Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Lisdexamfetamine Dimesylate Generics Distributors
  8. 8.2.3 Lisdexamfetamine Dimesylate Generics Customers
9 Global Lisdexamfetamine Dimesylate Generics Analyzing Market Dynamics
  1. 9.1 Lisdexamfetamine Dimesylate Generics Industry Trends
  2. 9.2 Lisdexamfetamine Dimesylate Generics Industry Drivers
  3. 9.3 Lisdexamfetamine Dimesylate Generics Industry Opportunities and Challenges
  4. 9.4 Lisdexamfetamine Dimesylate Generics Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst